GlycoNex (4168 TWO) stock market data APIs
NT$28.9602
-0.94(-3.2%)
as of January 27, 2026
Try our APIs with
free plan!
GlycoNex Financial Data Overview
Price chart is built with
Anychart
GlycoNex Incorporation engages in the development of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan. The company's development pipeline for the treatment of solid tumors includes GNX102, a humanized monoclonal antibody, currently under phase 1 clinical stage; GNX201, an antibody drug currently under preclinical stage; GNX203, glycan-directed antibody drug currently under the lead optimization stage; and GNX1021, a first-in-class antibody"drug conjugate currently under preclinical stage. It is also involved in the development of SPD (Denosumab), a humanized IgG2 antibody that is in phase 3 clinical trial for the treatment of osteoporosis and cancer bone metastases. The company was incorporated in 2001 and is based in New Taipei City, Taiwan.
Prev. Close
28.9602
Open
28.0172
High
29.3834
Low
27.7803
52 wk Range
15.6-30.95
Market Cap
3 211 M
Shares Outstanding
111 M
Revenue
36 634 K
EPS
-0.5466
Beta
0.546
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GlycoNex data using free add-ons & libraries
Get GlycoNex Fundamental Data
GlycoNex Fundamental data includes:
- Net Revenue: 36 634 K
- EBITDA: -187 950 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-05-31
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GlycoNex News
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
